Since loss of E-cadherin is a marker of EMT, it might be worthwhile to examine other EMT markers such as MMPs, which lead to E-cadherin degradation [37], or vimentin in multicentric/multifocal versus unifocal breast tumors. This evidence concerns the gene CDH1 and breast neoplasm.